A cross-sectional survey of hospitalization and blood tests implementation status in patients who received tolvaptan under 75 years of age using a Japanese claims database.

Shungo Imai Kenji Momo Hitoshi Kashiwagi Yuki SatoTakayuki MiyaiMitsuru Sugawara Yoh Takekuma

Published in: Expert opinion on drug safety (2021)

Our results highlight the deviation from Japanese package insert recommendations. This approach can be applied to other drugs and provides important perspectives on pharmacovigilance research.

Keyphrases

adverse drug
primary care
healthcare
health insurance
drug induced
clinical practice
acute heart failure
emergency department
atrial fibrillation
electronic health record